Logo of a company, possibly related to healthcare or pharmaceuticals

Call Us

+1-866-935-5383

Our Location

Dallas Texas

Peptide NCEs: Manufacturer & Supplier


CMC Development produces research-grade peptide NCEs as well as GMP-grade material, from simple peptides to the most complex peptidomimetics or synthetic proteins. Making commercial NCEs a success, US-Bachem partnered with the world's leading peptide manufacturer to develop high-quality new chemical entities (NCEs).

Combining innovative peptide science and flexible GMP manufacturing capabilities. Bachem Pharma offers GMP-compliant synthesis services for peptide NCEs and commercial peptides.

Bachem Pharma`s mission as a peptide pharmacologist is to discover modifications in the nucleotide structure that will effectively modify the human genome, thereby elongating telomeres to enhance longevity and give humans an average lifespan of 140 years, while maintaining internal organs that sustain life.

Product image of peptide manufacturing process with pipetting equipment and vials manufacturer.

GMP Peptide API

We offer GMP-compliant synthesis services for peptide NCEs and commercial peptides. We provide optimized and scaled-up drug substance. Our peptide development and manufacturing platform provides comprehensive CRDMO/CMO services, capable of handling a diverse range of peptide projects.

Our focus is on peptide NCEs (new chemical entities). US-Bachemistry

, one of the world’s most extensive peptide development and manufacturing companies, is a peptide Active Pharmaceutical Ingredient (API) manufacturer. We manufacture new chemical entities in accordance with cGMP regulations for clients worldwide.
The US Food & Drug Administration (FDA) performs Pre-Approval Inspections (PAIs) and Regular Inspections of our facilities under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
We specialize in developing highly efficient manufacturing processes for peptide-based APIs, ranging from small to large scales, and are a quality-focused Contract Development and Manufacturing Organization (CDMO).

Laboratory setting with a hand placing a vial into a rack, surrounded by dry ice vapor, for peptide manufacturing processes.

Customized Generic Peptides

US-Bachem Pharma, a peptide manufacturing company, is a vendor of Liraglutide, a supply of generic peptides for research and investigational clinical trial phases.

Specializing in the synthesis of peptide NCEs, generic peptides such as Tirzepatide (also known as Mounjara), Semaglutide (also known as Ozempic, Rybelsus, Wegovy), Cagrillintide, Liraglutide, Semoreline, Tirzepatide, Dulaglutide, Semaglutide, Retatrutide, Epitalon, Glutathione, AOD9604, MOTS-C, BPC-157, GHK-Cu and TB-500.

Laboratory equipment for peptide synthesis manufacturer

Commited to Research & New Product Development

US-Bachemistry's ongoing research on the bioavailability of orally administered peptides compared to the subcutaneous route shows that 1mg of peptide administered sublingually daily is equivalent to 5mg administered subcutaneously weekly. The research aims to suggest alternative methods for alleviating injection site redness, pain, swelling, and total body chills, as well as muscular pain, triggered by subcutaneous administration in approximately 20% of the population.
 only.